AEPCX | WAISX | AEPCX / WAISX | |
Total Expense Ratio | 1.59 | 1.30 | 122% |
Annual Report Gross Expense Ratio | 1.59 | 4.53 | 35% |
Fund Existence | 24 years | 6 years | - |
Gain YTD | -5.671 | -1.505 | 377% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 3.58M | 3,185,247% |
Annual Yield % from dividends | 0.35 | 0.00 | - |
Returns for 1 year | -12.63 | 3.97 | -318% |
Returns for 3 years | -10.52 | -4.15 | 253% |
Returns for 5 years | 23.92 | 30.60 | 78% |
Returns for 10 years | 0.07 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CREEX | 9.15 | -0.41 | -4.29% |
Columbia Real Estate Equity Inst | |||
AZEMX | 10.20 | -0.53 | -4.94% |
Alger Emerging Markets Z | |||
JHUKX | 28.85 | -1.63 | -5.35% |
JPMorgan Emerging Markets Equity R4 | |||
GCVCX | 20.62 | -1.34 | -6.10% |
Goldman Sachs Large Cp Val Insghts C | |||
FBTTX | 21.22 | -1.43 | -6.31% |
Fidelity Advisor Biotechnology M |